METTL3 and nasopharyngeal carcinoma: Correspondingly, we also used siRNA targeting METTL3 to construct METTL3 knockdown cells (Figure 5E), CCK-8 and clonogenic survival assays revealed that METTL3 knockdown promoted the radiosensitivity of NPC cells after radiotherapy (Figure 5F-G).